Paper11489331
The physiology of the lymphatic system.
Swartz MA. Adv Drug Deliv Rev, 2001. Cited by 557 papers, by iCite.
Cite this record
ConductScience Library. The physiology of the lymphatic system. Papers, record 11489331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11489331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphatic System | Major topic |
| Animals | |
| Humans | |
| Lymphatic Metastasis |
Source PubMed
Cited by299
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 557 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42828332 | Genetic polymorphism of the ovine MAP3K5 gene and its association with body size traits in Hu sheep of China. | Arch Anim Breed | 2023 | https://conductscience.org/library/papers/42828332 | PubMed |
| 42711970 | Non-Invasively Quantitative Raman Imaging for Calculation of Lymphatic Transport Kinetics of Micelles in Mice. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42711970 | PubMed |
| 42687072 | A Review on Lymphatic Uptake of Large Therapeutic Proteins after Subcutaneous Injection. | Pharm Res | 2026 | https://conductscience.org/library/papers/42687072 | PubMed |
| 42621458 | Lymphedema: current treatment strategies and future directions in tissue engineering. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42621458 | PubMed |
| 42620023 | Bone Lymphatic Endothelial Cells Form a Distinct Skeletal Population and Drive Skeletal Repair. | bioRxiv | 2026 | https://conductscience.org/library/papers/42620023 | PubMed |
| 42512321 | Routes of Cancer Dissemination: Distinguishing Lymphatic and Hematogenous Spread from Venous Entry to Systemic Arterial Distribution. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512321 | PubMed |
| 42450572 | Inflammatory Signal Persistence in Pain: Lymphatic Regulation and Neuroimmune Integration. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42450572 | PubMed |
| 42444830 | A mechanovascular framework for pre-neoplastic microenvironmental dysregulation and early carcinogenesis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42444830 | PubMed |
| 42416354 | A novel method for targeting lymphatic vessel imaging: methylene blue nanoparticle integrated with dissolvable microneedles. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42416354 | PubMed |
| 42347334 | Smart Nanomaterials and Natural Biologics for Innate-Adaptive Immune Reprogramming: A Nanobiotechnology Framework for Translational Medicine. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/42347334 | PubMed |
| 42324687 | Task-Evoked Functional Activation and Coupling With CSF Flow Detected in the Human Brain With Ultrashort Echo Time fMRI at 7 T. | NMR Biomed | 2026 | https://conductscience.org/library/papers/42324687 | PubMed |
| 42310715 | Exosome engineering and molecular tools for targeted therapy of brain-infecting pathogens: delivery systems, signaling pathways, and therapeutic applications. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42310715 | PubMed |
| 42014446 | High-yield isolation and characterization of microvascular niche cells from human full-thickness skin biopsies. | Sci Rep | 2026 | https://conductscience.org/library/papers/42014446 | PubMed |
| 42002047 | Engineering the subcutaneous delivery of antibody-drug conjugates. | J Control Release | 2026 | https://conductscience.org/library/papers/42002047 | PubMed |
| 41960287 | Metal-on-metal hip implants: Revisiting degradation product chemistry and molecular mechanisms of ARMD. | Biomater Biosyst | 2026 | https://conductscience.org/library/papers/41960287 | PubMed |
| 41940068 | Large animal models for the assessment of snakebite envenoming therapies. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/41940068 | PubMed |
| 41862512 | Macrophages recruited by implanted fibrin gels promote regeneration of injured lymphatic vessels. | Sci Rep | 2026 | https://conductscience.org/library/papers/41862512 | PubMed |
| 41623168 | Targeting lymphatic vessels enhances bone regeneration by augmenting osteoclast activity in mouse models of amputation. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41623168 | PubMed |
| 41566883 | Bioengineered Lymphatic Vessels in Synthetic Matrices to Study Breast Cancer Cell Functions. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41566883 | PubMed |
| 41241114 | Harnessing albumin as a carrier for the delivery of anti-HIV drugs to the lymphatic system. | Acta Biomater | 2026 | https://conductscience.org/library/papers/41241114 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11489331
GET https://conductscience.org/api/papers/v1/11489331/cited_by?page=2